3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine
C21H22FN9O — CID 66551704
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine
3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine (PubChem CID 66551704) has the molecular formula C21H22FN9O and a molecular weight of 435.47 g/mol. Its IUPAC name is 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine.
Molecular Properties
| Compound Name | 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine |
|---|---|
| PubChem CID | 66551704 |
| Molecular Formula | C21H22FN9O |
| Molecular Weight | 435.47 g/mol |
| Exact Mass | 435.19 |
| IUPAC Name | 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(2-morpholin-4-ylethyl)imidazo[1,2-b]pyridazin-6-amine |
| SMILES | Fc1cccnc1Nc1ncc(-c2cnc3ccc(NCCN4CCOCC4)nn23)cn1 |
| InChI | InChI=1S/C21H22FN9O/c22-16-2-1-5-24-20(16)28-21-26-12-15(13-27-21)17-14-25-19-4-3-18(29-31(17)19)23-6-7-30-8-10-32-11-9-30/h1-5,12-14H,6-11H2,(H,23,29)(H,24,26,27,28) |
| InChIKey | AWBZWMFDDAZDBC-UHFFFAOYSA-N |
| XLogP | 2.21 |
| TPSA | 105.39 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.47 |
| LogP ≤ 5 | 2.21 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66551704 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.